US company that makes biopreservation media and tools used to keep living cells healthy during storage and transport for cell and gene therapies.
| Date | Round | Amount |
|---|---|---|
| Jul 2026 | Acquired by Repligen Repligen agreed to acquire BioLife Solutions, a US maker of biopreservation media for cell and gene therapy, in a deal valued at about 1.5 billion dollars. BioLife shareholders will receive 31 dollars per share in cash and Repligen stock. | $1.5B |
Data is community-curated and may be incomplete.